Results

Total Results: 545 records

Showing results for "stimulants".

1. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
   May 01, 2006 - Two erythropoietic stimulants are available commercially in the United States, epoetin alfa (Epogen®, … Erythropoietic stimulants are widely used in clinical practice to manage anemia of patients undergoing … Although it is well established that erythropoietic stimulants improve anemia in patients undergoing … The limited evidence available (five studies, N=688) does not suggest that erythropoietic stimulants … Whether erythropoietic stimulants accelerate progression of some cancers, as reported by one study (n

2. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/cancer-anemia/research
   May 23, 2006 - Excerpt This review compares the efficacy and adverse effects of specific erythropoietic stimulants … This review also addresses questions relevant to optimizing the use of erythropoietic stimulants as a

3. Treating Disruptive Behavior Disorders in Children and Teens (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
   August 01, 2016 - XR®, Metadate CD®, Metadate ER®, Methylin®, Methylin ER®, Ritalin®, Ritalin LA®, Ritalin SR®) ��Stimulants … ��Stimulants can be short acting (work for 4 to 6 hours) or long acting (work for 8 to 12 hours). … Approved for children aged 6 and older Stimulants may improve disruptive behavior.* Nonstimulant … ��Stimulants can be habit forming. … ��Stimulants may cause growth problems in children.

4. Treating Disruptive Behavior Disorders in Children and Teens | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
   August 31, 2016 - Stimulants Examples include: Mixed amphetamine salts (Adderall®, Adderall XR®) Methylphenidate … Stimulants can be short acting (work for 4 to 6 hours) or long acting (work for 8 to 12 hours). … Approved for children aged 6 and older Stimulants may improve disruptive behavior.* Nonstimulant … Stimulants can be habit forming. … Stimulants may cause growth problems in children.The height and weight of children taking a stimulant

5. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
   February 01, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease Erythropoietins Data Points #4 The findings described herein were presented by Thomas MaCurdy, Ph.D., at the Medicare Evidence Development & Coverage Advisory Committee meeting held on March 24, 2010,…

6. ADHD Medications and Risk of Serious Coronary Heart Disease in Young and Middle-Aged Adults | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/adhd-heart-disease-children/research
   December 12, 2011 - Abstract Background More than 1.5 million U.S. adults use stimulants and other medications labeled

7. Disruptive-Behavior-Disorder Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorder_executive.pdf
   October 01, 2015 - disruptive behaviors, are alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … Three RCTs (all high risk of bias) addressed risperidone (as initial treatment, to augment stimulants … Two RCTs reported that stimulants were more effective than placebo at reducing ODD and CD symptoms. … Stimulants (methylphenidate, amphetamine) Disruptive behaviors Low SOE for positive effects on … Interventions included antipsychotic drugs, an antiepileptic drug, and ADHD drugs (both stimulants

8. Executive Summary: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
   March 01, 2024 - Head-to-head comparisons did not detect statistically significant differences between stimulants and … non-stimulants for most effectiveness outcomes, such as ADHD symptoms (SMD 0.23; CI -0.03, 0.49; 7

9. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
   November 01, 2021 - population prevalence of rigorously diagnosed ADHD,31 suggesting that many youth may be receiving stimulants … The main categories of pharmacologic therapies include stimulants, selective norepinephrine reuptake … In children over the age of 5, the American Academy of Pediatrics (AAP) recommends stimulants as the … Searches will go back to 1980, when long acting stimulants were introduced, heralding the modern era … (methylphenidate, amphetamine) and non-stimulants (norepinephrine reuptake inhibitors, alpha agonists

10. Cancer-Anemia-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - for initiating treatment compare regarding their effect on the benefits and harms of erythropoietic stimulants … optimal duration of therapy compare regarding their effect on the benefits and harms of erythropoietic stimulants

11. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
    August 01, 2016 - range of psychotropic medications—including anticonvulsants, antipsychotics, mood stabilizers, and stimulants—have … improved in the intervention groups versus a control group over the short term (1–6 months). ��� Stimulants

12. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
    August 31, 2016 - range of psychotropic medications--including anticonvulsants, antipsychotics, mood stabilizers, and stimulants … [evidence medium] Stimulants** (methylphenidate, amphetamine) Disruptive behaviors 2 (2 RCTs)

13. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior.pdf
    August 18, 2022 - interventions16- 18 (considered first-line treatment) and/or pharmacotherapy (e.g., antipsychotics, stimulants … pharmacologic interventions including alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … antipsychotics - beta-adrenergic blocking agents (i.e., beta- blockers) - central nervous system stimulants

14. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/research-protocol
    July 01, 2014 - stabilizers, anticonvulsants, and psychostimulants. 42 Combination therapy with antipsychotics and stimulants … for disruptive behaviors, are alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … Beta-blockers Propranolol Metoprolol Pindolol Nadolol Central nervous system (CNS) stimulants … antipsychotics, beta-adrenergic blocking agents (i.e., beta-blockers), central nervous system (CNS) stimulants … [tiab] OR "Central Nervous System Stimulants"[Mesh] OR "Central Nervous System Stimulants" [Pharmacological

15. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
    January 30, 2014 - stabilizers, anticonvulsants, and psychostimulants.42 Combination therapy with antipsychotics and stimulants … for disruptive behaviors, are alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … antipsychotics, beta-adrenergic blocking agents (i.e., beta-blockers), central nervous system (CNS) stimulants … serotonin reuptake inhibitors"[tiab] OR "Serotonin Uptake Inhibitors" [Pharmacological Action] OR stimulants … [tiab] OR "Central Nervous System Stimulants"[Mesh] OR "Central Nervous System Stimulants" [Pharmacological

16. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
    October 01, 2011 - Amphet is in the search so it is just missing from the list of stimulants? … Gives equivocal support for long- term use of stimulants. … There was an upsurge in use in Western Australia of stimulants, at least compared to the other states … A related issue is whether the mild growth slowing from stimulants, now confirmed in multiple reports … For example, you conclude that the use of stimulants peaked in 2000. What was this based upon?

17. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
    September 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review Comparative Effectiveness Review Number 247 Interventional Treatments for Acute and Chronic Pain: Systematic Review Evidence Summary Main Points • Vertebroplasty …

18. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary.pdf
    September 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review Comparative Effectiveness Review Number 247 Interventional Treatments for Acute and Chronic Pain: Systematic Review Evidence Summary Main Points • Vertebroplasty …

19. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
    September 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review Comparative Effectiveness Review Number 247 Interventional Treatments for Acute and Chronic Pain: Systematic Review Evidence Summary Main Points • Vertebroplasty …

20. Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization
    March 31, 2011 - Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease Timeline March 31, 2011 Topic Initiated March 31, 2011 Research Report Data Points #4: Trends in the utilization of erythropoiesis…